Arbeitsgruppe Thorakale Onkologie - Studien
| Advanced and inoperable non-squamous non-small-cell lung cancer (NSCLC), 1st line | ||||
| AIO assoziierte Studie | zur Studie | |||
| Randomized Phase-II trial of three-weekly cisplatinum and pemetrexed versus split-dose d1 and d8 cisplatinum and pemetrexed in advanced and inoperable non-squamous non-small-cell lung cancer (NSCLC) (Pemetrexed/split-dose cisplatinum versus pemetrexed/cisplatinum in NSCLC) | ||||
| NSCLC - Stadium III - neoadjuvante/definitive Radiochemotherapie | ||||
| AIO assoziierte Studie | zur Studie | |||
| Prospective randomized phase-III trial of standard definitive boost radiotherapy versus surgery following induction chemotherapy with cisplatin/paclitaxel and neoadjuvant radiochemotherapy based on hyperfractionated accelerated radiotherapy ESPATÜ-trial-GCS-2.1 | ||||